Maria Bieniaszewska

First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells

Piotr Trzonkowski, Maria Bieniaszewska, Jolanta Juścińska et al. · Clinical Immunology · 2009 · 666 citations

Life Sciences, Clinical Sciences, Immunology +17

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes et al. · The Lancet Haematology · 2019 · 154 citations · Full text

Medicine, Hematology, Immunology +17

Effect of a 2‐hour infusion of 2‐chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia

A. Hellmann, Krzysztof Lewandowski, Jan Maciej Zaucha et al. · European Journal Of Haematology · 1999 · 63 citations

Medicine, Hematology, Pharmacology +12

Treosulfan compared with <scp>reduced‐intensity</scp> busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial

Dietrich W. Beelen, Matthias Stelljes, Péter Reményi et al. · American Journal of Hematology · 2022 · 61 citations · Full text

Medicine, Hematology, Oncology +17

Prevalence of acquired von Willebrand syndrome during essential thrombocythemia: a retrospective analysis of 170 consecutive patients

Andrzej Mital, Witold Prejzner, Maria Bieniaszewska et al. · Polskie Archiwum Medycyny Wewnętrznej · 2015 · 57 citations · Full text

Medicine, Hematology, Internal Medicine +13